Top Markets
#1 Nesa Nesa +808.96%
#2 Cortex Cortex +68.17%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.37%
#4 QuantixAI QuantixAI +23.90%
#5 EXOD EXOD +22.78%
#6 BSquared Network BSquared Network +18.87%
#7 Instadapp Instadapp +16.15%
#8 Pons Pons +15.93%
#9 Magma Finance Magma Finance +13.38%
#10 PondCoin PondCoin +13.28%
Coin of the day
Nesa Nesa
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Clasificación en acciones #3340
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Precio por acción
$6.23
Capitalización bursátil
$5.58B
Cambio (1 día)
-1.10%
Cambio (1 año)
25.53%
País
CN
Comercio Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Categoría

Healthcare
Ingresos de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH